Our study provides an insight into an lncRNA‐dependent regulation on the enzymatic activity of PKM2, and suggests a potential of targeting VAL or PKM2 as promising biomarkers in GC diagnosis and treatment. The gene discussed is LINC01546; the disease is gastric cancer.